Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

LEOPARD · Liver Electronic Offering Platform with Artificial intelligence-based Devices

HORIZONStatus: SIGNED1 November 202331 October 2028EU funding €6,320,857Call HORIZON-HLTH-2022-TOOL-12-two-stage

Liver transplantation (LT) is a life-saving procedure for decompensated cirrhosis (DC) and hepato-cellular carcinoma (HCC). Its efficacy is hampered by the risk of death/drop-out on the Wait List (WL). This risk is driven by organ shortage and is mitigated by organ offering schemes. According to a sickest first policy, offering schemes prioritize LT candidates with the highest risk of dying, as assessed by predictive models. To drive allocation, Organ Sharing Organizations (OSOs) use a 20-year-old model, the MELD, predicting mortality in DC but not in HCC. Because of a dramatic increase in % of HCC candidates (40% against 10% in early 20ties), MELD schemes are increasingly inaccurate, with persisting 15 to 30% mortality in countries with low/medium donation rate. This scenario, together with advances in prognosis in DC and HCC candidates and statistics, prompts LT community to look for up-dated algorithms to refine offering schemes. To address this issue, key European LT stakeholders including OSOs, experts in LT, Statisticians, Research Labs and SME joined LEOPARD. Building on an innovative, harmonized OSOs pre-LT dataset and advances in modeling, LEOPARD propose to design and validate 1) an AI-based LEOPARD predictive algorithm outperforming current allocation models by better stratifying patients on the risk of mortality, to be proposed OSOs to drive allocation; 2) DC & HCC LEOPARD calculators available for professional for assistance in complex decision-making processes; 3) OMICs/radiomics predictive signatures integrated in a prototype 3rd-generation exploratory model. We expect to generate computational tools improving candidates’ outcomes, with more patients transplanted on time. Adoption of these tools should result in harmonization of European heterogeneous prioritization schemes, and in a signification reduction in disparities of access to LT, a major objective pointed out by EC. LEOPARD should place Europe in leading position for organ offering schemes.

Consortium · 18 organisations

coordinator

ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

FR · €2,491,841

participant

ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK

FR · €876,799

participant

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

FR · €228,575

participant

ISTITUTO SUPERIORE DI SANITA

IT · €389,388

participant

AGENCE DE LA BIOMEDECINE

FR · €147,589

participant

FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA

ES · €273,025

participant

STICHTING EUROTRANSPLANT INTERNATIONAL FOUNDATION

NL · €41,250

participant

UNIVERSITE DU LUXEMBOURG

LU · €656,128

thirdParty

UNIVERSITATSKLINIKUM HEIDELBERG

DE

associatedPartner

UNIVERSITE PARIS CITE

FR

associatedPartner

EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER

CH

participant

OPHIOMICS - INVESTIGACAO E DESENVOLVIMENTO EM BIOTECNOLOGIA SA

PT · €358,558

participant

EUROPEAN SOCIETY FOR ORGAN TRANSPLANTATION

NL · €214,831

participant

EUROPEAN LIVER PATIENTS ASSOCIATION

BE · €83,125

participant

EPSA INNOVATION FRANCE

FR · €299,375

associatedPartner

ORGANIZACION NACIONAL DE TRASPLANTES

ES

participant

EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)

ES · €260,375

associatedPartner

Fédération Nationale des Malades et Transplantés Hépatiques

FR

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.